Story
Oct 26, 2026
Anthropic’s IPO Puts Its Safety Mission on Wall Street’s Clock
Anthropic presents its IPO as a way to finance transformative AI while preserving a safety-first mission, but outside coverage argues that the same filing exposes a sharper contradiction: a company asking public markets for capital while keeping meaningful control—and extraordinary technological risk—in insiders’ hands.
Anthropic formally began its public-market push on Monday, filing an S-1 registration statement with the Securities and Exchange Commission for a proposed Nasdaq listing under the ticker ANT. The company said neither the number of shares nor the price range had yet been determined.1
The filing turns a closely held AI lab into a test case for whether investors will embrace a business whose growth is as dramatic as its warnings are stark. Anthropic reported $16.3 billion in revenue for the first half of 2026, up from $1.2 billion a year earlier, alongside an $80.7 billion net loss. Much of that loss reflected a noncash adjustment tied to convertible notes, while operating losses narrowed to $693 million from $2.1 billion.2
Anthropic’s own pitch is expansive. It says AI could accelerate science, economic growth and disease cures, while pledging to manage “the risks that come with a technological revolution this fast and this powerful.”3 Its strategy rests on deepening enterprise use: more than 11,900 customers were spending at least $100,000 annually by late September, with a growing share using both its platform and first-party applications.4
But the prospectus also lays out the price of that ambition. Anthropic has committed hundreds of billions of dollars to cloud, compute and infrastructure, even as major customers and cloud partners could reduce demand or become more direct competitors. Its risk disclosures run more than 90 pages and warn that advanced systems could pose “catastrophic or existential risks to humanity,” including through misuse, autonomy or failures of oversight.5
Governance is likely to become the IPO’s most contentious feature. Seven co-founders, through a Founder LLC, will control 50.1% of voting power, while Anthropic’s Long-Term Benefit Trust can appoint most directors. The company says the arrangement protects long-term value and its public-benefit mission; critics argue it leaves ordinary shareholders with capital at risk but little practical influence.6
That is the central Wall Street bargain: investors can buy into one of AI’s fastest-growing companies, but not necessarily get a vote on how it navigates the dangers it says may accompany the technology.